Clinical Trial Update: Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China [Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 3 study evaluating eculizumab in adult participants with paroxysmal nocturnal hemoglobinuria in China; the trial h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• SOLIRIS (eculizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | Status: COMPLETED